Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

Katherine Nabel Smith(Brigham and Women's Hospital), Jonathan Abraham(Michigan State University), Guohai Zhou(Brigham and Women's Hospital), Haley Varnum(Harvard University), Yao Fan(Sun Yat-sen University), Anhdao T. Darcy(AbbVie (United States)), Richelle C. Charles(Massachusetts General Hospital), Davide Tavella(AbbVie (United States)), Casey Tylek(AbbVie (United States)), Michaël Desjardins(Centre Hospitalier de l’Université de Montréal), Lindsay G. A. McKay(Boston University), Sarah E. Turbett(Harvard University), Adrian Coscia(Harvard University), Edward T. Ryan(Harvard University), Regina C. LaRocque(Massachusetts General Hospital), Amy C Sherman(Dana-Farber Cancer Institute), Junhua Pan(Boston Children's Hospital), Vesna Brusic(Harvard University), Joël F.G. Cohen-Solal(AbbVie (United States)), Anthony Griffiths(Boston University), Lars E. Clark(Harvard University), Nicole V. Tolan(Brigham and Women's Hospital), Ivan Correia(AbbVie (United States)), Anca Clabbers(AbbVie (United States)), Sundaresh Shankar(Harvard University), Jane Seagal(Boston Children's Hospital), Sarah A. Clark(NHS Lothian), Lindsey R. Baden(Brigham and Women's Hospital), Sanjat Kanjilal(National Center for Chronic Disease Prevention and Health Promotion), Pan Yang(Harvard University), Anand S. Dighe(Harvard University)
Science
January 21, 2022
Cited by 88


Related Papers